1. Home
  2. LNN vs DRTS Comparison

LNN vs DRTS Comparison

Compare LNN & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$116.17

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$14.92

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
DRTS
Founded
1954
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
LNN
DRTS
Price
$116.17
$14.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$113.00
$8.67
AVG Volume (30 Days)
92.3K
483.3K
Earning Date
04-02-2026
05-18-2026
Dividend Yield
1.35%
N/A
EPS Growth
12.81
N/A
EPS
4.22
N/A
Revenue
$676,368,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.74
$699.98
P/E Ratio
$27.52
N/A
Revenue Growth
11.41
N/A
52 Week Low
$97.27
$3.14
52 Week High
$148.00
$14.75

Technical Indicators

Market Signals
Indicator
LNN
DRTS
Relative Strength Index (RSI) 56.06 66.63
Support Level $116.15 $6.59
Resistance Level $120.01 N/A
Average True Range (ATR) 3.16 0.68
MACD 0.25 0.09
Stochastic Oscillator 81.63 97.43

Price Performance

Historical Comparison
LNN
DRTS

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: